David R. Webb, Ph.D.

Dr. Webb is an Adjunct Professor in the Department of Integrative Structural and Computational Biology at The Scripps Research Institute. He is also Chairman of the Board at Agragene, Inc. and the Chief Executive Officer of Synbal, Inc., a platform technology company that is commercializing CRISPR-based breakthrough active genetic technologies developed at the University of California, San Diego.

Dr. Webb is the former Vice President and Research Site Head at Celgene-San Diego. Between 1995 and 2003, he held a series of senior management positions in several biotechnology companies where he developed and led drug discovery programs focused on inflammation, asthma, cancer, and diabetes. Notable companies include Syrrx, OSI Pharmaceuticals, and Cadus Pharmaceutical Corporation, where he was the Vice President of Research and Chief Scientific Officer from 1995 to 1999. Dr. Webb was also an Adjunct Professor of Microbiology and Immunology at New York Medical College.

From 1987 to 1995, Dr. Webb was at Syntex, Inc. where he held the positions of Distinguished Scientist and, later, Director of the Institute of Immunology and Biological Sciences. Dr. Webb was also a Consulting Professor of Cancer Biology at Stanford University. From 1973 to 1987, he was a member of the Department of Cell Biology at the Roche Institute of Molecular Biology and Adjunct Associate Professor at Columbia University, College of Physicians and Surgeons.

Dr. Webb earned his Ph.D. in Microbiology/Immunology from Rutgers University and both a B.A. and M.A. in Biology from California State University, Fullerton.